Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|February 9, 2026
Keratin 5 marks cancer-propagating cells sustained by an osteopontin-producing niche in high-grade serous ovarian carcinomaMallikarjun Bidarimath, Coulter Q Ralston, Nandini Bidarimath, et al.
The American Journal of Pathology|April 23, 2003
Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomasRong Wu, Lin Lin, David G Beer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Frequent downregulation of miR-34 family in human ovarian cancersDavid C Corney, Chang-Il Hwang, Andres Matoso, et al.
American Journal of Obstetrics and Gynecology|March 10, 2007
Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine modelMichael R Milam, Joseph Celestino, Weiguo Wu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 20, 2024
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservationBeryl L Manning-Geist, Eric Rios-Doria, Ying L Liu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservationBeryl L Manning-Geist, Eric Rios-Doria, Ying L Liu, et al.
Molecular Oncology|July 20, 2024
ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability-high (MSI-H) molecular subtypeMelica Nourmoussavi Brodeur, Pier Selenica, Weining Ma, et al.
Gynecologic Oncology|October 27, 2023
TERT promoter mutations and gene amplification in endometrial cancerAaron M Praiss, Antonio Marra, Qin Zhou, et al.
Cancer|August 16, 2024
Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancerMackenzie W Sullivan, Stephen Graves, Anusha Adkoli, et al.
Gynecologic Oncology|September 27, 2024
Lymph node metastases in endometrial carcinoma: A modern assessment in the era of sentinel lymph node mapping and molecular subtypingAaron M Praiss, Christian Dagher, Qin Zhou, et al.
Pageof 10